All In Biotech

Drug Trial Radar · NCT05322850

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients With Hematologic Malignancies (HM)

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Aug 16, 2022

Primary completion

Sep 2027

Study completion Sep 2028

Sponsor

Lead sponsor
University of FloridaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Orca Biosystems, Inc.
First posted
Apr 12, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a first in children prospective study of allogeneic hematopoietic cell transplant using a centrally manufactured engineered donor graft (Orca-Q). The study will assess safety and efficacy of Orca-Q in pediatric patients with hematologic malignancies.

Conditions

  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
  • Mixed Phenotype Acute Leukemia
  • Acute Undifferentiated Leukemia
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis)
  • Chronic Myeloid Leukemia - Accelerated Phase

Interventions

  • Orca-QBiological

    All transplant recipients enrolled on this study in both the phase I and phase II portions will receive Orca-Q (Orca-Q Prime and Orca-Q Supplement) intravenously following myeloablative conditioning.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary graft failureTime frame: 28 days
  2. Secondary graft failureTime frame: 100 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of Florida

    Gainesville, Florida · Recruiting

  • University of Miami

    Miami, Florida · Suspended

  • Nicklaus Children's Hospital

    Miami, Florida · Suspended

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida · Suspended

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.